-+ 0.00%
-+ 0.00%
-+ 0.00%

Abbott Laboratories Announces REFLECT Real-World Studies Results That Shows Use Of FreeStyle Libre Continuous Glucose Monitoring Technology Associated With Significant Reduction In Risk Of Hospitalization For Heart Complications In People With Diabetes.

Benzinga·05/15/2025 13:12:17
Listen to the news
  • New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes.1
  • This significant decrease is linked to the use of Libre biowearable technology compared to traditional blood glucose monitors.1
  • Results also show a reduction in hospitalization for cardiovascular complications in adults with Type 2 diabetes on insulin using Libre technology.2